Robert G. Bristow, MD, PhD, on Prostate Cancer: Keynote Lecture

2018 Genitourinary Cancers Symposium

Robert G. Bristow, MD, PhD, of Manchester Cancer Research Centre, discusses germline and somatic mutations; new ways to generate biomarkers that may describe tumor complexity; and how, in the future, this information may help triage patients with aggressive prostate tumors to intensified treatments.

Aug

Today In Oncology

Cory Wiegert Named New CEO of CancerLinQ LLC

ESR1 Fusions and Metastasis in Estrogen Receptor–Positive Breast Cancer

Assay Uses Big Data to Predict Responses to Immunotherapy

FDA Grants 510(k) Clearance to SRT-100+ Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancer and Keloids

CNS Activity of EGFR Tyrosine Kinase Inhibitor in T790M-Positive Advanced NSCLC

;